Effects of SUlodexide on damaged endothelial Glycocalyx in pAtients with diabetes Mellitus type two: Reversing damage
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Sulodexide (Primary)
- Indications Diabetic nephropathies; Embolism and thrombosis; Proteinuria; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SUGAR
- 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
- 04 Jan 2007 New trial record.